Cluster 1 was characterized by KMT2A fusion partners MLLT3 and MLLT10, whereas Cluster 3 comprised mainly ELL and MLLT4. Interestingly, all LS AML samples were assigned to Cluster 2, which contained various other fusion partners. This evidence concerns the gene AFDN and acute myeloid leukemia.